BioSpace News Archive

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announced the pricing of an underwritten public offering of 9,000,000 shares of its Class A common stock, offered at a price to the public of $5.00 per share.

Technavio has announced its latest market research report titled global vascular embolization devices market 2020-2024.

Invisian Medical awarded Innovative Technology group purchasing contract by Vizient to offer patent-pending Minne Ties fixation technology for jaw fractures and other jaw-related surgeries to its members

Mitchell Hamline School of Law is pleased to announce the first annual Roy Snell Health Care Regulatory & Compliance Writing Competition.

Pharnext SA, a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on big genomics data and artificial intelligence, announced the establishment of an equity line facility to enhance the Company’s financial flexibility and improve liquidity for shareholders.

MedinCell will hold an audio conference for its shareholders and the financial community on Tuesday, December 3 to present the results of the first half-year 2019-2020, which ended on September 30, 2019:

Convergent Imaging Solutions will be featuring enterprise nuclear medicine processing capabilities in its widely used UniSyn Image Fusion software suite, at the 2019 Radiological Society of North America meeting, December 1-6, in Chicago, IL.

Regenstrief Institute is investing and partnering with Care Revolution, a medical startup focused on improving care at nursing facilities, controlling costs and reducing trips to the hospital.

Gut microbiome analysis experts Microba had three of their researchers – including both co-founders – named in the 2019 Highly Cited Researchers list by the Web of Science Group released yesterday.

Eisai Co., Ltd. announced that it has launched the Equfina 50mg TABLETS for the indication of improvement of the wearing-off phenomenon in patients with Parkinson’s disease under treatment with a drug containing levodopa in Japan.